Statement of Changes in Beneficial Ownership (4)
August 27 2019 - 4:58PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Cancelmi Daniel J |
2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP
[
THC
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) EVP & Chief Financial Officer
|
(Last)
(First)
(Middle)
1445 ROSS AVENUE, SUITE 1400 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
8/23/2019
|
(Street)
DALLAS, TX 75202
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock (1)
|
8/23/2019
|
|
M
|
|
16694
|
A
|
(2)
|
271783
|
D
|
|
Common Stock (3)
|
8/23/2019
|
|
M
|
|
56713
|
A
|
(2)
|
328496
|
D
|
|
Common Stock
|
8/23/2019
|
|
F
|
|
28886 (4)
|
D
|
$20.74
|
299610
|
D
|
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code (Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)
|
8. Price of Derivative Security (Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
2014 August Restricted Stock Units
|
(1)
|
8/23/2019
|
|
M
|
|
|
16694
|
(1)
|
(1)
|
Common Stock (5)
|
16694
|
$0.00
|
0
|
D
|
|
2014 August Performance-Based Restricted Stock Units
|
(3)
|
8/23/2019
|
|
M
|
|
|
56713
|
(3)
|
(3)
|
Common Stock (5)
|
56713
|
$0.00
|
0
|
D
|
|
Explanation of Responses:
|
(1)
|
As previously reported, on 8/25/14, the reporting person received a grant of 16,694 time-based restricted stock units that vest in their entirety on the fifth anniversary of the date of grant. The fifth anniversary occurred on 8/23/19 (the business day prior to the anniversary date, which fell on a weekend), resulting in the vesting and settlement of 16,694 shares of common stock, as shown in Table I.
|
(2)
|
Restricted stock units convert into common stock on a one-for-one basis.
|
(3)
|
On 8/25/14, the reporting person received a target grant of 33,390 performance-based restricted stock units, scheduled to vest on the fifth anniversary of the date of grant subject to the Company's attainment of specified performance goals and the level of achievement thereof. The performance goals were exceeded, and the award was certified at a payout of 56,713 units. The fifth anniversary occurred on 8/23/19 (the business day prior to the anniversary date, which fell on a weekend), resulting in the vesting and settlement of 56,713 shares of common stock, as shown in Table I.
|
(4)
|
Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
|
(5)
|
Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock upon vesting.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Cancelmi Daniel J 1445 ROSS AVENUE SUITE 1400 DALLAS, TX 75202
|
|
|
EVP & Chief Financial Officer
|
|
Signatures
|
Mark R. Jackson, as Attorney-in-Fact for Daniel J. Cancelmi
|
|
8/27/2019
|
**Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person, see Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Tenet Healthcare (NYSE:THC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tenet Healthcare (NYSE:THC)
Historical Stock Chart
From Sep 2023 to Sep 2024
See More Message Board Posts
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.